Jyong Biotech Ltd. (MENS) Form 10-Q Quarterly Reports
Jyong Biotech Ltd. (MENS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MENS
CIK: 1954488
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WWC, P.C.
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerShurong Ciou
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 20-F | 2026-05-15 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-057073 | View SEC Doc Filr Page |
| NT 20-F | 2026-04-29 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-049070 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-24 | — | SCHEDULE 13D Filing | 0001213900-26-047468 | View SEC Doc Filr Page |
| 3 | 2026-04-14 | 2026-04-13 | PRIMARY DOCUMENT | 0001096906-26-000531 | View SEC Doc Filr Page |
| 3 | 2026-04-08 | 2026-04-08 | PRIMARY DOCUMENT | 0001096906-26-000502 | View SEC Doc Filr Page |
| 3 | 2026-04-01 | 2026-04-01 | PRIMARY DOCUMENT | 0001096906-26-000465 | View SEC Doc Filr Page |
| 3 | 2026-04-01 | 2026-04-01 | PRIMARY DOCUMENT | 0001096906-26-000463 | View SEC Doc Filr Page |
| 3 | 2026-04-01 | 2026-04-01 | PRIMARY DOCUMENT | 0001096906-26-000462 | View SEC Doc Filr Page |
| 3 | 2026-04-01 | 2026-04-01 | PRIMARY DOCUMENT | 0001096906-26-000460 | View SEC Doc Filr Page |
| 3 | 2026-04-01 | 2026-04-01 | PRIMARY DOCUMENT | 0001096906-26-000458 | View SEC Doc Filr Page |
| 6-K | 2026-02-06 | 2026-02-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-013306 | View SEC Doc Filr Page |
| 6-K | 2026-01-09 | 2026-01-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-002944 | View SEC Doc Filr Page |
| SP 15D2 | 2025-06-30 | 2024-12-31 | SP 15D2 | 0001213900-25-059643 | View SEC Doc Filr Page |
| 6-K | 2025-06-20 | 2025-06-18 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-055711 | View SEC Doc Filr Page |
| 424B4 | 2025-06-18 | — | PROSPECTUS | 0001213900-25-055414 | View SEC Doc Filr Page |
| EFFECT | 2025-06-16 | — | EFFECT Filing | 9999999995-25-001932 | View SEC Doc Filr Page |
| CERT | 2025-06-16 | — | CERT Filing | 0001354457-25-000534 | View SEC Doc Filr Page |
| 8-A12B | 2025-06-12 | — | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-25-053888 | View SEC Doc Filr Page |
| CORRESP | 2025-06-12 | — | CORRESP Filing | 0001213900-25-053881 | View SEC Doc Filr Page |
| CORRESP | 2025-06-12 | — | CORRESP Filing | 0001213900-25-053878 | View SEC Doc Filr Page |
| POS AM | 2025-06-06 | — | REGISTRATION STATEMENT | 0001213900-25-052132 | View SEC Doc Filr Page |
| POS AM | 2025-04-23 | — | POST-EFFECTIVE AMENDMENT | 0001213900-25-034511 | View SEC Doc Filr Page |
| EFFECT | 2025-03-31 | — | EFFECT Filing | 9999999995-25-000866 | View SEC Doc Filr Page |
| CORRESP | 2025-03-28 | — | CORRESP Filing | 0001013762-25-003778 | View SEC Doc Filr Page |
| CORRESP | 2025-03-28 | — | CORRESP Filing | 0001013762-25-003777 | View SEC Doc Filr Page |